Prosecution Insights
Last updated: August 18, 2026

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (83%)
0
Medium (0%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§112 only1 (17%)
Multi-statute (no §101)4 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
17% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLLWEG, THOMAS A 1 53.1% +31.4%
PERRIN, CLARE M 1 67.9% +42.3%
EPSTEIN, TODD MATTHEW 1 61.0% +44.2%
MULLINS, BURTON S 1 68.9% +1.7%
PALENIK, JEFFREY T 1 53.8% +26.8%
OGUNBIYI, OLUWATOSIN A 1 63.7% +41.5%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18277898 SELF-SUPPORTING VISCIN FILMS AND SCAFFOLDS, USES THEREOF AND METHODS FOR PREPARING THE SAME PALENIK, JEFFREY T 20d
18799012 OPTICAL FIBER FEEDTHROUGH FOR A VACUUM CHAMBER HOLLWEG, THOMAS A
18725259 NANOFILAMENT-COATED MEMBRANES WITH HIERARCHICAL POROUS STRUCTURES, IN PARTICULAR FOR MEMBRANE DISTILLATION, AND METHODS FOR PREPARING THE SAME PERRIN, CLARE M
18691525 BIOCHEMICAL PATHWAY FOR THE PRODUCTION OF TULIPALIN A VIA ITACONIC ACID EPSTEIN, TODD MATTHEW
18554843 MAGNETICALLY COUPLED DRIVE ARRANGEMENT MULLINS, BURTON S

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18277898 SELF-SUPPORTING VISCIN FILMS AND SCAFFOLDS, USES THEREOF AND METHODS FOR PREPARING THE SAME PALENIK, JEFFREY T 20d
18799012 OPTICAL FIBER FEEDTHROUGH FOR A VACUUM CHAMBER HOLLWEG, THOMAS A
18725259 NANOFILAMENT-COATED MEMBRANES WITH HIERARCHICAL POROUS STRUCTURES, IN PARTICULAR FOR MEMBRANE DISTILLATION, AND METHODS FOR PREPARING THE SAME PERRIN, CLARE M
18691525 BIOCHEMICAL PATHWAY FOR THE PRODUCTION OF TULIPALIN A VIA ITACONIC ACID EPSTEIN, TODD MATTHEW
17767476 IMMUNOGENIC PEPTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF MALARIA OGUNBIYI, OLUWATOSIN A

Top Art Units

Art UnitApps
1652 1
2834 1
1615 1
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18799012 OPTICAL FIBER FEEDTHROUGH FOR A VACUUM CHAMBER HOLLWEG, THOMAS A §102§103§112 Non-Final OA Pending Aug 09, 2024
18725259 NANOFILAMENT-COATED MEMBRANES WITH HIERARCHICAL POROUS STRUCTURES, IN PARTICULAR FOR MEMBRANE DISTILLATION, AND METHODS FOR PREPARING THE SAME PERRIN, CLARE M §103§112 Non-Final OA Pending Jun 28, 2024
18691525 BIOCHEMICAL PATHWAY FOR THE PRODUCTION OF TULIPALIN A VIA ITACONIC ACID EPSTEIN, TODD MATTHEW 1652 §102§103 Non-Final OA Pending Mar 13, 2024
18554843 MAGNETICALLY COUPLED DRIVE ARRANGEMENT MULLINS, BURTON S 2834 §102§103 Final Rejection Pending Oct 11, 2023
18277898 SELF-SUPPORTING VISCIN FILMS AND SCAFFOLDS, USES THEREOF AND METHODS FOR PREPARING THE SAME PALENIK, JEFFREY T 1615 §101§102 Final Rejection 20d Pending Aug 18, 2023
17767476 IMMUNOGENIC PEPTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF MALARIA OGUNBIYI, OLUWATOSIN A 1645 §112 Non-Final OA Pending Apr 08, 2022

Managing Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month